Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CAT-354 5 mg/kg
BIOLOGICAL
2 trials
Sponsors
MedImmune LLC
Conditions
Asthma
Moderate Asthma
Phase 1
A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma
Terminated
NCT00974675
MedImmune LLC
Moderate Asthma
Start: 2006-09-29
End: 2007-08-03
Updated: 2017-05-02
Phase 2
A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma
Terminated
NCT00640016
MedImmune LLC
Asthma
Start: 2008-01-31
End: 2008-07-31
Updated: 2017-01-31
Related Papers
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma.
2010-01-08
51 citations